• Article / Chapter
  • Initiation of antidepressants in patients infected with SARS-COV-2

Initiation of antidepressants in patients infected with SARS-COV-2 : Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution

This article is a commentary on: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution by Borovcanin, M. M., Vesic, K., Balcioglu, Y. H., and Mijailović, N. R. (2022). Front. Psychiatry 13:1052710. doi: 10.3389/fpsyt.2022.1052710

Preview

Category

Date Issued:
13.03.2023
URN:
urn:nbn:de:hbz:465-20230818-084443-7
DOI:
10.3389/fpsyt.2023.1095244
Language:
English
Type of Resource:
Text
Keywords:
antidepressants; SNRI; SSRI; COVID-19; adverse effects; panic attacks; nausea; jitteriness
Collection:
E-Publications
Subject categories of the Deutsche Nationalbibliografie:
610 Medical sciences Medicine
Hosting institution:
Faculty of Medicine, Essen University Hospital, LVR-Klinikum Essen, Klinik für Psychiatrie und Psychotherapie
funding:

The publication of this article was supported by the Publication Fund of the University of Duisburg-Essen.

Info on primary publication:

Bonnet U (2023) Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution. Front. Psychiatry 14:1095244. doi: 10.3389/fpsyt.2023.1095244

Published: 13 March 2023

version identification:
Version of Record / Verlagsversion

Cite

Citation style:
Could not load citation form.

Rights

License Holder:

© 2023 Bonnet

Use and reproduction:
This work may be used under a
CC BY 4.0 LogoCreative Commons Attribution 4.0 License (CC BY 4.0)
.